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Abstract: Patient-specific patterns of abnormal perfusion are useful indicators in the diagnosis
and monitoring of patients suffering from a microvascular dysfunction. Arterial Spin Labeling
(ASL), as an entirely non-invasive magnetic resonance imaging technique, is a promising tool to
image perfusion and the General Linear Model (GLM) could be used in order to quantitatively
detect abnormal patterns of perfusion at the individual level in ASL.
In this paper, patient-specific perfusion abnormalities were therefore identified by comparing a sin-
gle patient to a group of healthy controls using a mixed-effect hierarchical GLM. Two approaches
are currently in use to solve hierarchical GLMs: (1) the homoscedastic approach assumes homoge-
neous variances across subjects and (2) the heteroscedastic approach is theoretically more efficient
in the presence of heterogeneous variances but algorithmically more demanding. In practice, in
functional magnetic resonance imaging studies, the superiority of the heteroscedastic approach is
still under debate. Due to the low signal-to-noise ratio of ASL sequences, within-subject variances
have a significant impact on the estimated perfusion maps and the heteroscedastic model might
be better suited in this context.
In this paper we studied how the homoscedastic and heteroscedastic approaches behave in terms
of specificity and sensitivity in the detection of patient-specific ASL perfusion abnormalities. Val-
idation was undertaken on a dataset of 25 patients diagnosed with brain tumors and 36 healthy
volunteers. We showed evidence of heterogeneous within-subject variances in ASL and pointed out
an increased false positive rate of the homoscedastic model. In the detection of patient-specific
brain perfusion abnormalities with ASL, modeling heterogeneous variances increases the sensitivity
at the same specificity level.
Key-words: Arterial Spin Labeling, Hypo-perfusion, Hyper-perfusion, General Linear Model,
Within-subject variance, Heteroscedasticity
Détection d’anomalies de perfusion en prenant en compte
les variances intra- et inter- sujets en imagerie par
marquage de spins artériels
Résumé : Dans ce travail, les anomalies de perfusion chez un patient sont identifiées, en
imagerie par marquage de spins artériels (Arterial Spin Labeling), grâce à une comparaison
entre la carte de perfusion du patient et un modèle de perfusion normale obtenu à partir d’un
groupe de contrôles sains. Pour effectuer cette comparaison, deux approches sont possibles :
(1) l’approche homoscédastique qui suppose une homogénéité des variances chez les différents
individus et (2) l’approche hétéroscédastique qui est théoriquement plus efficace en présence de
variances hétérogènes mais plus coûteuses algorithmiquement. En pratique, en Imagerie par
Résonance Magnétique fonctionnelle, la supériorité de l’approche hétéroscédastique est encore
sujet à débat. En ce qui concerne les séquences par marquage de spins artériels (ASL), les
variances intra-sujet ont un impact significatif sur l’estimation de la perfusion et on peut se
demander si le modèle hétéroscédastique n’est pas plus adapté dans ce contexte.
Nous étudions ici comment les approches homoscédastique et hétéroscédastique se comportent
en termes de sensibilité et spécificité pour la détection d’anomalies de perfusion en ASL. La
validation est effectuée sur un ensemble de 25 patients présentant des tumeurs cérébrales et
36 volontaires sains. Nous montrons l’hétérogénéité des variances intra-sujets en ASL, ainsi que
l’augmentation du taux de faux positifs dû au modèle homoscédastique. En ce qui concerne la
détection des anomalies de perfusion cérébrale en ASL, modéliser l’hétérogénéité des variances
augmente la sensibilité pour le même niveau de spécificité.
Mots-clés : Marquage de spins artériels, Hypo-perfusion, Hyper-perfusion, variance intra-sujet,
Hétéroscédasticité
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1 Introduction
Brain perfusion is the biological process that ensures the delivery of oxygen and nutrients to
the cerebral tissues by means of micro-circulation. As an indicator of the well-being of the
tissues, perfusion is a useful measurement for diagnosis in clinical practice. Identifying regions
of abnormal perfusion, either hypo-perfusions or hyper-perfusions, can help understanding the
mechanism of a disease and taking care of the patient. For instance, for patients diagnosed
with tumors, the clinician is interested in hyper-perfusions that would reveal the grade of the
tumor [44], or help differentiating between post-radiation necrosis and tumor recurrence [38]. In
strokes, the extent of hypo-perfusion and mismatch with diffusion imaging provide an insight on
the possible recovery of the tissue [19].
Arterial Spin Labeling (ASL), a Magnetic Resonance Imaging (MRI) technique introduced
in the early 1990’s, allows to measure the level of perfusion through a quantitative index: the
cerebral blood flow (CBF). Contrary to standard perfusion imaging, including Positron Emission
Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) in nuclear
medicine, or Dynamic Susceptibility weighted Contrast (DSC) in MRI, ASL is completely non-
invasive and does not require the injection of an exogenous contrast agent. In ASL, blood water,
used as an endogenous tracer, is labeled with a radio-frequency pulse. After a delay called inver-
sion time, a labeled image of the brain is acquired. A control image is also acquired without prior
labeling. The difference between the labeled and the control image leads to a perfusion-weighted
map. To increase the Signal-to-Noise Ratio (SNR) of the measure, the acquisition is repeated
several times. The absence of radiation and the use of an endogenous tracer, which removes the
need of injecting a contrast agent, are clear advantages of ASL over standard perfusion imaging
techniques. The ASL sequence however suffers from a low SNR, which is still a serious obstacle
for its use in clinical practice.
Since the introduction of ASL, and despite its low SNR, a large number of studies have demon-
strated its usefulness in identifying patterns of abnormal perfusion at the group level (e.g. [34]).
To date, identification of individual patterns of hypo- and hyper-perfusions in patients with ASL
mainly relies on visual analysis [50, 12]. Very few ASL studies focused on voxelwise quantitative
perfusion abnormality detections at the individual level. In [33], a template-based analysis was
presented in order to detect individual activation patterns in functional ASL data. Interestingly,
they also applied their method to a pathological case in order to detect a hypo-perfusion co-
located with a dysplasia in an epileptic patient. While their approach opens the field to the
detection of patient-specific perfusion abnormalities with ASL, a single pathological case was
presented and no quantitative validation performed. Their detections relied on z-scores, but in a
more general setting, the most widespread approach to compare voxel-wise maps in neuroimag-
ing is the massively univariate General Linear Model (GLM). To detect differential patterns
between two groups with repeated measurements a subtype of GLM is employed: a mixed-effect
hierarchical two-sample t-test with two levels: subject and group. In this context, two variance
components are of interest: the within-subject variance (or the measurement error, estimated
from the repeated ASL acquisitions of a single subject) and the between-subject variance.
In the functional MRI community, where similar statistical models are applied, two ap-
proaches are currently in use to solve hierarchical GLMs. On the one hand, the homoscedastic
approach, also termed “summary statistics” [31], or referred as “ordinary least square estimation”
[26, 27] or “conventional group analysis” [11], assumes homogeneous within-subject variances or
negligible within-subject variances by comparison to between-subject variance. On the other
hand, the heteroscedastic approach, also referred as “full mixed-effect” [16, 39, 35], “mixed-effect
model” [11] or “weighted least square estimation” [26, 27] models heterogeneous within-subject
variances. There is indeed a large panel of homonyms to refer to these two approaches, in cur-
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rent practice they are also sometimes referred as “mixed-effect” and “random-effect” approaches
[20]. However, in a statistical sense both the homoscedastic and the heteroscedastic approaches
are mixed-effect models. That is why, in the context of this paper, we chose to term the two
approaches “homoscedastic model” and “heteroscedastic model” to identify them according to
their main difference: the homoscedasticity (constant within-subject variance across subjects)
assumption.
The homoscedastic model is theoretically less efficient in the presence of heterogeneous within-
subject variances. However, in practice, the true variance components are unknown and the
superiority of the heteroscedastic model is therefore questioned. Whether modeling heteroge-
neous variances should be preferred over the homoscedastic model is still under discussion in
the fMRI community. Several authors outlined the benefits of heteroscedastic models including
[48, 6, 47, 26, 25, 39, 11]. However, [27] showed that the homoscedastic approach is still valid
with near optimal sensitivity in the context of one-sample t-tests. Nonetheless, the same authors
acknowledged that, in two-sample t-tests, appropriate modeling of heterogeneous within-subject
variances might be crucial [27, 35]. Recently the conclusions regarding one-sample t-tests were
revisited leading to opposite conclusions [11]. In the different software packages currently avail-
able to deal with fMRI data both approaches are represented: SPM1 favors the homoscedastic
approach [18] while FSL2 [47], AFNI3 [13] and fmristat4 [48] use the heteroscedastic model.
In ASL, the importance of the within-subject variance has been outlined by [40]. While we
previously investigated the ability to detect hypo- and hyper-perfused regions using a template
of normal perfusion in two conference papers [22, 23], here, we focus on the comparison of the
homoscedastic and heteroscedastic approaches. We further improve on these papers by providing
quantitative measure of heterogeneity. Also, a larger database is studied and a novel quantitative
validation is performed.
In this paper, we focus on quantitative detections of pathological brain perfusion abnormal-
ities at the individual level. To this aim, we employ and compare two GLM-based models: the
homoscedastic and heteroscedastic approaches. We test whether the assumptions underlying the
homoscedastic approach are verified in pulsed ASL datasets. We furthermore study how the
homoscedastic and heteroscedastic approaches behave in terms of specificity and sensitivity in
the detection of patient-specific perfusion abnormalities.
A quantitative validation is performed on a dataset of 25 patients diagnosed with brain
tumors. Though there is no well-defined ground truth, this pathology was selected since patterns
of hypo- and hyper-perfusions have been widely studied in this clinical context. The model of
normal perfusion is computed out of the data of 36 healthy volunteers.
Section 2 begins with a presentation of the homoscedastic and heteroscedastic models em-
ployed in the detection of patient-specific brain perfusion abnormalities with ASL. Then, the
experiments designed to test the assumptions of the homoscedastic model and measure sensitiv-
ity and specificity are presented. Section 3 presents the datasets under study: the acquisition and
pre-processing are described. The results are presented in section 4. Section 5 gives a discussion
and concludes.
2 Methods
In 2.1, the homoscedastic and heteroscedastic models and their implementation in the context
of patient-specific detection of perfusion abnormalities in ASL are presented. Then, in 2.2, the
1http://www.fil.ion.ucl.ac.uk/spm
2http://fsl.fmrib.ox.ac.uk/fsl/fslwiki
3http://afni.nimh.nih.gov/afni
4http://www.math.mcgill.ca/keith/fmristat
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experiments undertaken in order to test the assumptions of the homoscedastic model and to
compare the homoscedastic and heteroscedastic models are described.
2.1 Detection of patient-specific perfusion abnormalities using a mixed-
effect hierarchical two-sample t-test
This section presents the common massively univariate GLM usually employed for voxel-based
analysis in the neuroimaging community. The main assumption behind the GLM is the linearity
of the effects. Moreover, Gaussian noise is usually assumed. In the standard approach, the GLM
is defined for each voxel, which is why this approach is often termed “massively univariate”. For
ease of notation the voxel index is omitted in the remainder of the paper.
In the context of this paper, we aim at outlining areas of abnormal perfusion in the perfusion
map of a subject of interest by comparison to a group of healthy controls. We hence focus on
a subtype of GLM: a one-versus-many mixed-effect two-sample t-test. As several measurements
are available for each subject, a hierarchical model is defined with 2 levels: subject and group.
Since the subject under study is usually an individual suffering of a pathological condition,
the term patient will be used in the following. This approach is nevertheless suited for the
comparison of any single subject (control, patient) to a group of individuals.
A description of the subject level is proposed in 2.1.1. In 2.1.2 the group level is presented
along with a description of the two main related approaches: the homoscedastic and heterosce-
dastic models. Lastly, hypothesis testing performed in order to outline the perfusion abnormali-
ties is discussed in 2.1.3.
2.1.1 Subject level (First level)
Given a voxel, for each subject s we have:
Ys = Xs βs + s, (1)
where Ys is a vector containing the observations at the given voxel, βs is the set of subject
parameters to be estimated, Xs is the subject-level design matrix and s contains the residual
errors. In the following, we assume that the data can be described with a single parameter per
subject, βs, however more parameters (e.g. nuisance covariates as in [42]) could be considered.
In fMRI, Xs is closely related to the time-course of the paradigm under study. In ASL, at
the subject level, the data under study is a 4D volume of CBF maps containing V volumes (1
per repeated acquisition). The observations Ys are therefore repeated measurements of a same
underlying value and the Xs matrix is a vector of ones. Then, the model reduces to:
Ys =
1...
1
 βs + s.
Assuming Gaussian noise of the errors, s follows a normal distribution: s ∼ N (0, σ2s). While,
in fMRI, temporal autocorrelation must be accounted for [2], in ASL, thanks to the subtraction
process between control and labeled scans, we can reasonably assume white noise [1, 26]. The
subject parameter βs is thus estimated by Ordinary Least Squares (OLS):
βˆs =
1
V
V∑
i=1
ys,i, (2)
Inria
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where ys,i is the ith element of vector Ys. Similarly, the sampling variance of βˆs is estimated by:
V̂ar(βˆs) =
σˆ2s
V
where σˆ2s =
1
V − 1
V∑
i=1
(
ys,i − βˆs
)2
. (3)
2.1.2 Group level (Second level)
In a general setting, in a group of n subjects, the subject parameters (βs)1≤s≤n can be combined
using the following model: β1...
βn
 = XG βG + γG, (4)
where XG is the group-level design matrix, βG the group parameters and γG the residual
error term (outlining the intra-group variability). In a one-sample t-test, XG would be a vector
of ones and βG contain a single estimate. In our context, the subjects are part of two groups
(n−1 controls in the first group and 1 patient in the second) and βG is a vector with 2 elements.
Let βcontrols and βpatient be the control group and patient parameters. Without loss of generality,
we assume that subjects 1 to n− 1 are part of the control group and subject n is the patient of
interest. Then the second-level model reduces to:
β1
...
βn−1
βn
 =

1 0
...
...
1 0
0 1

[
βcontrols
βpatient
]
+ γG. (5)
Assuming Gaussian errors, γG follows a normal distribution γG ∼ N (0, σ2G), where σ2G is the
common between-subject (also termed “within-group” or even “group”) variance of both groups.
Indeed, since in a one-versus-many study, a single subject is available in the patient group,
estimating a different variance for each group (control, patient) is impractical.
However, the true subject parameters are in fact unknown and, in practice, their estimates
from the first level are used in the second-level leading to a slightly different model:
βˆ1
...
βˆn−1
βˆn
 =

1 0
...
...
1 0
0 1

[
βcontrols
βpatient
]
+ γGC . (6)
The new error term γGC is impacted by two combined sources of variations: the error measure-
ment on the subject parameters (also termed within-subject variance) and the between-subject
variance. Each element of γGC therefore follows a normal distribution: γsGC ∼ N
(
0, σ2G +
σ2s
V
)
.
Linear combinations of the group parameters can be calculated using a particular contrast.
Here we are interested in the patient versus control group contrast:
b = [1 − 1]
[
βcontrols
βpatient
]
= βcontrols − βpatient . (7)
Two approaches have been proposed in the neuroimaging literature to solve the system (6) and
find an estimate of the patient versus control group contrast, bˆ, and its associated sampling vari-
ance, V̂ar(bˆ). The homoscedastic approach assumes homoscedasticity while the heteroscedastic
RR n° 8216
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approach explicitly models heterogeneous within-subject variances. Both models are described
hereafter.
Homoscedastic model The homoscedastic model is based on the assumption that the within-
subject variance is either negligible by comparison to the between-subject variance (i.e. σ2s 
σ2G, ∀ 1 ≤ s ≤ n) or, roughly constant across subjects (i.e. σ2s ≈ σ2SUB , ∀ 1 ≤ s ≤ n). Then
each element of γGC follows a normal distribution:
γsGC ∼ N (0, σ2GC ) (8)
where σ2GC is the combined within- and between-subject variance. Depending on the assumption,
we have σ2GC = σ
2
G+
σ2SUB
V
or σ2GC ≈ σ2G and the combined within- and between-subject variance
is therefore constant across subjects. The sphericity assumption (no heteroscedasticity and no
autocorrelation) hence holds and the system (6) is then solved by OLS to get:
βˆHOMOcontrols =
1
n− 1
n−1∑
s=1
βˆs
βˆHOMOpatient = βˆn ,
(9)
The associated sampling variances are:
V̂ar(βˆHOMOcontrols) =
σˆ2GC
n− 1
V̂ar(βˆHOMOpatient) = σˆ
2
GC
where σˆ2GC =
1
(n− 1)− 1
n−1∑
s=1
(
βˆs − βˆHOMOcontrols
)2
.
(10)
As a consequence, the patient versus control group contrast b is estimated by:
bˆHOMO = βˆHOMOcontrols − βˆHOMOpatient =
1
n− 1
n−1∑
s=1
βˆs − βˆn , (11)
and the sampling variance of this estimator is:
V̂ar
(
bˆHOMO
)
= σˆ2GC
( 1
n− 1 + 1
)
. (12)
Heteroscedastic model In the heteroscedastic model, heterogeneous variances are accounted
for. As described earlier, in the general case, each element of γGC follows a normal distribution:
γsGC ∼ N (0, σ2G +
σ2s
V
). (13)
Due to the non-sphericity of the measurement errors (as a consequence of heteroscedasticity),
the system (6) is solved by using a weighted least square to get:
βˆHETEROcontrols =
1∑n−1
j=1 wj
n−1∑
s=1
ws βˆs
where ws =
1
σˆ2G + σˆ
2
s
βˆHETEROpatient = βˆn .
(14)
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The associated sampling variances are:
V̂ar(βˆHETEROcontrols) =
1∑n−1
s=1 ws
V̂ar(βˆHETEROpatient ) = σˆ
2
G + σˆ
2
n .
(15)
The within-subject variance estimates, σˆ2s , are computed at the subject level as described in
eq. (3). In this paper, we compute σˆ2G using a recent computationally efficient approach available
in the MEMA function of the AFNI software package and described in [11].
The patient versus control group contrast b is estimated by:
bˆHETERO = βˆHETEROcontrols − βˆHETEROpatient
=
1∑n−1
j=1 wj
n−1∑
s=1
ws βˆs − βˆn (16)
and the sampling variance of this estimator is:
V̂ ar
(
bˆHETERO
)
=
1∑n−1
s=1 ws
+ σˆ2G + σˆ
2
n . (17)
If homoscedasticity is respected then it can easily be proven that this model reduces to the
homoscedastic model. However, in the presence of heteroscedasticity, the heteroscedastic model
has two main advantages by comparison to the homoscedastic model:
1. In the control group, observations with high within-subject variances are downweighted in
order to provide a more efficient estimate of the control group parameter, βˆHETEROcontrols .
2. While with the homoscedastic model the sampling variance of the patient group estimate,
V̂ar(βˆHOMOpatient), depends solely on variance estimations performed in the control group, the
heteroscedastic sampling variance, V̂ar(βˆHETEROpatient ), takes advantage of both the control group
(estimation of σ2G) and the patient (estimation of σ
2
n) data.
The impact on the efficiency of the control group estimate (point 1) might be subtle and
leads to no substantial improvement in one-sample t-tests if the homoscedasticity assumption is
not overly altered [27]. However, the impact on the variance estimate of the patient parameter
(point 2) can be large if the within-subject variance of the patient of interest is very different
from the control subjects. In ASL studies, the large influence of within-subject variance has been
described in [40]. Furthermore, patients are known to be less cooperative than control subjects
which could potentially lead to within-subject variance inflation due to increased movement.
We therefore expect that adjusting for the proper patient within-subject variance, using the
heteroscedastic instead of the homoscedastic model, will lead to more accurate results in the
detection of patient-specific perfusion abnormalities.
2.1.3 Hypothesis testing
Under the null hypothesis:
H0 : βcontrols = βpatient , (18)
the estimated patient versus control group contrast, bˆ, divided by its estimated sampling standard
deviation (V̂ar(bˆ))
1
2 follows a t-distribution with n− 1 degrees of freedom.
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A probability under the null hypothesis can therefore be calculated for each voxel with:
P (X < x) where X =
bˆ√
V̂ar(bˆ)
∼ Tn−1, (19)
and x is the value taken by X at the voxel of interest. Equation (19) gives the probability to
have a hyper-perfusion, similarly, hypo-perfusions can be detected by substituting P (X < x) by
P (X > x). The thresholding of this probability map gives the detections.
2.2 Evaluation framework
In this subsection, we first present how the ground truth hypo- and hyper-perfusions were deter-
mined based on anatomical and perfusion information (2.2.1). Then, the experiments undertaken
to verify the assumptions of the homoscedastic model (2.2.2) and to compare the homoscedastic
and heteroscedastic models (2.2.3) are presented.
2.2.1 Ground truth
Quantitative assessment of the detections and comparison between detection methods are chal-
lenging tasks. This is mainly because, like in many other medical imaging problems, the ground
truth is not clearly stated. We chose to evaluate this framework on patients diagnosed with
tumor pathology because perfusion abnormalities have been widely studied in this clinical con-
text [9, 38, 43, 44, 10]. Also, as perfusion is a useful clinical information, DSC is part of the clinical
routine for these patients. Based on clinical knowledge, we used a semi-automatic procedure that
took advantage of the complementary anatomical (T1w-Gd, T2w FLAIR) and perfusion (DSC)
information to get an estimation of the ground truth.
True positives According to clinical knowledge, T1w-Gd hypersignals are usually indicative of
the presence of hyper-perfusions [44]. However, in some tumor types they are related to a different
phenomenon. For instance, in lymphomas the hypersignal identified on the T1w-Gd map does
not correspond to a hyper-perfusion [44]. Moreover, neoangiogenesis, which is characterized by
hyper-perfusions in ASL, can spread out of the T1w-Gd hypersignal in particular in high grade
tumors such as glioblastoma [17]. Ground truth hyperperfused regions based on the T1w-Gd
hypersignal are therefore imprecise.
To overcome these limitations, we applied a two-step procedure taking advantage of both the
anatomical and perfusional information (delivered by DSC CBF). In order to get an estimation
of the ground truth, we implemented a method inspired by the hotspot technique [28] commonly
used in clinical practice. To this aim, the tumor was first segmented using a semi-automated
method based on the T2w and T1w-Gd images and visually inspected by an expert neuro-
radiologist. Then, we compared the tissue segmented as part of the tumor to its controlateral
counterpart in the DSC CBF map. Voxels overtaking the lower and upper deciles were identified
as potential hypo- and hyper-perfusions. Each potential perfusion abnormality was then visually
inspected by an expert neuro-radiologist and manually corrected if needed. Special care was
taken in order to avoid inclusion of hyper-perfusions related to the presence of arteries.
Due to its low SNR, ASL is not well suited to measure low levels of perfusion [45]. That is
why, we focused on hyper-perfusions for sensitivity estimation. Hypo-perfusions were nevertheless
retained for specificity calculations.
Out of the 17 patients included in this study who underwent a DSC sequence, 9 presented
hyper-perfusions, 16 hypo-perfusions and 8 both.
Inria
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False positives According to clinical knowledge, in the absence of metastasis, the perfusion
abnormalities should be confined to the affected tissue (tumor and oedema) identifiable on T1w-
Gd and T2w. The proportion of non-affected tissue detected as a perfusion abnormality was
used as a measure of the false positive rate.
In the control group, in which no detections were expected, an additional estimate of the
specificity was calculated by leave-one-out cross-validation.
2.2.2 Validity of the assumptions of the homoscedastic model
The homoscedastic model makes the assumption that within-subject variance is either negligible
by comparison to between-subject variance, or roughly constant across subjects [27]. In order to
test each of these assumptions, we performed two experiments.
Negligible within-subject variance First, following [11], we measured the proportion of
total variability that occurred within subjects with the following index, defined at each voxel for
each subject s:
λs =
σˆ2s
σˆ2G + σˆ
2
s
(20)
Values close to 1 mean that the within-subject variance (σ2s) is preponderant compared to
between-subject variance (σ2G) and values close to 0 mean that between-subject variance holds
the majority of the total variance. This measure is provided as an output of the MEMA function
in AFNI [11].
Constant within-subject variance across subjects In a second experiment, we focused
on the within-subject variance to verify whether it could be assumed roughly constant across
subjects. To this aim, we calculated an average within-subject variance for each subject. This
index was computed as suggested by [27] by averaging the within-subject variance for voxels
within the interquartile range of the nonzero between-subject variance. Given this index of
within-subject variance, we searched for outliers in the control group with Rosner’s test [36],
assuming that the distribution of the variance estimate was approximately normal. Then, we
checked whether the control and patient groups had significantly different medians with a non-
parametric Kruskal-Wallis test.
2.2.3 Comparison of the homoscedastic and heteroscedastic models
Detections at a fixed threshold In order to assess the difference that heteroscedasticity
modeling would induce, we compared the sensitivity and specificity of the homoscedastic and
heteroscedastic models. We compared both approaches in a usual setting, where the detections
were identified at a threshold p < 0.05 with False Discovery Rate (FDR) correction for multiple
comparisons [7]. As the data is usually pre-smoothed with a Gaussian kernel at the end of the
pre-processing, we studied 6 kernel sizes defined by their full-width at half maximum (FWHM):
0 mm3 (i.e. no smoothing), 4 mm3, 6 mm3, 8 mm3, 10 mm3, 12 mm3.
ROC analysis In order to further assess the difference that heteroscedasticity modeling would
induce, we compared the sensitivity and specificity of the homoscedastic and heteroscedastic
models with Receiver-Operating-Characteristics (ROC) curves. In order to draw the ROC curves,
we used 122 p-values (uncorrected), equally spaced in the logarithmic space. ROC curves provide
a way to measure the performance of a classifier without focusing on a single threshold. We
calculated the area under the curve as an indicator of the classification accuracy. Since the size
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of the expected detections is much smaller than the number of voxels that must not be detected,
the area of interest in the ROC curve is the one of high specificity. That is why, as previously
proposed in the literature, we focused on the area under the curve corresponding to false positive
rates ranging from 0% to 10% [37]. As in the previous experiment, different smoothing kernels
were studied.
3 Materials
This section starts with a presentation of the datasets under study (3.1). The pre-processing
steps applied to the data before the statistical analysis are then described (3.2).
3.1 Data acquisition
25 patients diagnosed with brain tumors and 36 healthy volunteers were involved in this study.
One control subject and four patients were excluded because of strong borderzone signs [49].
The final dataset therefore included 21 patients (13 males, 8 females, age: 55.2 ± 14.1 years)
and 35 healthy volunteers (16 males, 19 females, age: 27.7 ± 6.4 years).
Data acquisition was performed on a 3T Siemens Verio MR scanner with a 32-channel head-
coil. Patients were scanned in the context of clinical practice. The imaging protocol included a
3D T1-weighted anatomical sequence (T1w) (TR: 1900 ms, TE: 2.27 ms, FOV: 256 mm× 256 mm
× 176 mm, flip angle: 9◦, resolution: 1 mm × 1 mm × 1 mm), a PICORE Q2TIPS sequence [46]
with crusher gradients (TR: 3000 ms, TE: 18 ms, FOV: 192 mm × 192 mm, flip angle: 90◦,
resolution: 3 mm × 3 mm, slice thickness: 7 mm, inter-slice gap: 0.7 mm, TI: 1700 ms, TIwd:
700 ms, 60 repetitions, mSENSE parallel imaging with accelerating factor of 2). In addition
to these sequences, the patients also underwent a 3D T1w post gadolinium (T1w-Gd) sequence
(TR: 1900 ms, TE: 2.27 ms, flip angle: 9◦, FOV: 250 mm × 250 mm ×176 mm, resolution: 1 mm
× 1 mm × 1 mm) and a 2D T2w FLAIR sequence (TR: 9000 ms, TE: 90 ms, FOV: 220 mm
× 199.4 mm, flip angle: 150◦, resolution: 0.69 mm × 0.69 mm, slice thickness: 4 mm). Out
of the 22 patients, 17 subjects also underwent a DSC sequence (GRE EPI, TR: 1500 ms, TE:
30 ms, FOV: 230 mm× 230 mm, flip angle: 90◦, in plane resolution: 1.8 mm × 1.8 mm, slice
thickness: 4 mm, inter-slice gap: 1.2 mm).
3.2 Pre-processing
In this subsection, we present how raw ASL images were processed in order to compute CBF
maps (3.2.1) and then normalized in intensity (3.2.2). Lastly, DSC pre-processing is briefly
described (3.2.3)
3.2.1 CBF estimation with ASL
Image pre-processing was performed using SPM8 (Statistical Parametric Mapping 8, Wellcome
Department of Imaging Neuroscience, University College, London) in Matlab R2012a (Math-
works, Natick, MA). The anatomical image of each subject was segmented using the unified
segmentation [4]. A subject-specific anatomical brain mask was created, excluding voxels with
less than 50% of brain tissue in subsequent statistical analyses. A six-parameter rigid-body reg-
istration of the ASL volumes was carried out in order to reduce undesired effects due to subject
motion. Rigid coregistration onto the whole-brain anatomical map was then performed based
on mutual information. The average of unlabeled volumes was used to estimate the geometri-
cal transformation to apply to each volume. Pair-wise subtraction of the control and labeled
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scans was then computed. A standard kinetic model [8] was applied in order to get ASL CBF,
according to the following equation:
f = 6000× λ∆M
2 M0 αTIwd exp−(TI+idxsl∗TI sl)/T1b
(21)
where f is the 4D CBF map in mL.100g−1.min−1, M0 the acquired M0 map (first volume
of the ASL serie), λ = 0.9 mL.g−1 the blood/tissue water partition coefficient, α = 0.95 the
labeling efficiency, ∆M the 4D perfusion-weighted map, TI = 1.7 s the inversion time [15], idx sl
the slice index (0 for the first slice), TI sl = 0.045 s the duration of acquisition of one slice,
TIwd = 0.7 s the temporal width of the bolus, TI b = 1.5 s the T1 of blood [41]. The 6000 factor
allows the conversion from mL.g−1.s−1 to mL.100g−1.min−1 which is the standard unit for CBF.
We bring the attention of the reader to the fact that, contrary to what is usually done in ASL
pre-processing, ∆M represents the set of perfusion-weighted maps (one volume per repetition)
instead of a single perfusion-weighted map obtained by averaging across the repetitions. This is
necessary in order to allow for the measurement of the within-subject variance.
Spatial normalization parameters estimated during the segmentation step were then applied
to the T1 and ASL CBF maps in order to normalize the subjects into the ICBM-452 T1 template
space [24]. This registration algorithm was selected since it gives good results even in the presence
of large anatomical lesions [14].
3.2.2 Intensity normalization
Intensity normalization is a common pre-processing step in PET or SPECT analysis [3] where the
measured values are not quantitative. ASL produces quantitative CBF maps, but the large inter-
subject variability in global CBF [30] induces a strong correlation across voxels. In voxelwise ASL
detection studies, where the focus is on local variations across the brain, intensity normalization
is therefore advised to increase the sensitivity [5]. Given CBF s,v, the original CBF value of
subject s at voxel v, Perf s,v, the normalized intensity value and θs the cross-voxel normalization
parameter, we have:
CBF s,v = θs × Perf s,v. (22)
The most widespread approach to estimate θs in ASL data processing is to compute the mean
CBF signal found in a given region of interest (ROI). This ROI is either limited to an anatomical
region, which is known to be avoided by the pathology under study, or covers the whole normal
grey matter [5]. A threshold of 70% of grey matter is often chosen [32]. The latter approach was
preferred in this study since, in a general setting, no brain region is free of anomalies across all
pathologies. Unphysiological negative perfusion estimates were excluded from the normalization
mask.
Furthermore, as areas of abnormal perfusion should not be included in the normalization
mask, we used an iterative scheme. At the first step, the normalization parameter was computed
based on a mask covering the entire grey matter of the patient map under study. A first pass
outlined the corresponding perfusion abnormalities as described in section 2.1.3. On the next
step, the detected voxels were excluded from the intensity normalization estimation. These two
steps were iterated until convergence.
3.2.3 CBF estimation with DSC
The DSC images were processed using MR manufacturer software by manually choosing an
arterial input function to calculate: the CBF, cerebral blood volume, and mean transit time
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maps. The method is based on a deconvolution algorithm as described in [29]. Similarly to ASL,
DSC CBF maps were coregistered on anatomical maps and spatially normalized.
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Figure 1: Parameter estimates of the homoscedastic and heteroscedastic model in the control
group, computed from 35 healthy subjects. a) Mean perfusion estimate βˆHETEROcontrols . b) Combined
within- and between-subject standard deviation estimate from the homoscedastic model σˆGC . c)
Between-subject standard deviation estimate from the heteroscedastic model σˆG. d) Root square
of the average within-subject variance in the control group. Perfusion is expressed in normalized
units (ratio to mean grey matter perfusion). Axial slices are displayed in neurological convention.
4 Results
In this section we start with a graphical presentation of the parameter estimates of the homosce-
dastic and heteroscedastic models in the control group (4.1). Then, we present the results of the
experiments regarding the validity of the assumptions of the homoscedastic model (4.2). In a
last subsection, we display the results of the quantitative comparison between the homoscedastic
and heteroscedastic models (4.3).
4.1 ASL template: a model of normal perfusion
In fig. 1, the parameter estimates of the homoscedastic and heteroscedastic models are displayed.
Each parameter is defined as a voxelwise map. First, an estimate of the control group parameter is
provided (βˆHETEROcontrols is displayed, the homoscedastic estimate βˆ
HOMO
controls is visually nearly identical).
As expected, the CBF is higher in the cortex and the basal ganglia than in white matter. Then,
three standard deviation estimates are displayed:
• the combined within- and between-subject standard deviation estimate σˆGC from the homo-
scedastic model (1 b);
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Figure 2: Histogram of the ratio of within-subject variance onto total variance in the control
group. Both variance estimates have a significant impact depending on the voxels.
• the between-subject standard deviation estimate σˆG from the heteroscedastic model (1 c);
• the root square of the average within-subject variance estimates in the control group
( 1n−1
∑n−1
s=1 σˆ
2
s)
1
2 . This map is not part of the estimated standard deviations but is pro-
vided as a visual example of expected within-subject standard deviation in the control
group (1 d).
The high variance values observed in the vascular structures, such as the transverse sinus, are
in concordance with the findings of [40]. This pattern is clearly visible in the combined within-
and between-subject variance estimate of the homoscedastic model and captured by the within-
subject variance estimate in the heteroscedastic model. The main variations observed in the
between-subject variance, as estimated in the heteroscedastic model, are related to inter-subject
misregistrations in the cortex. An increased variance is also visible in the occipital lobe, probably
related to increased arterial transit times in these regions [21].
4.2 Testing the assumptions of the homoscedastic model
The homoscedastic model stands on one of the following assumptions: either the within-subject
variance is negligible by comparison to between-subject variance, or the within-subject variance
is roughly constant across subjects.
4.2.1 Relative weights of between-subject and within-subject variances in the con-
trol group
In order to verify if the within-subject variance can be assumed negligible by comparison to
between-subject variance, fig. 2 presents the histogram of the ratio of within-subject to total
variance in the control group (λs from eq. (20)). Overall, a total of 1 094 790 voxels are considered.
Values close to one indicate a preponderance of the within-subject variance, whereas values close
to zero outline a dominating between-subject variance. Clearly, both components of variance
have an important impact as the λs index spans the complete range of values between 0 and
1. The large peak indicating voxels with a zero between-subject variance was also observed in
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Figure 3: Average estimated within-subject variances in control and patient groups. For each
box, the red line corresponds to the median and the top and bottom lines of the blue square are
the upper and lower quartiles of the distribution.
[11] and might be the consequence of calculation inaccuracies. While the true between-subject
variance might not be exactly zero, these voxels nevertheless present a very small between-
subject variance, negligible by comparison to the within-subject variance. The quartiles of the
distribution are 0.23 and 0.78, so that the outermost 25% of the voxels (on each side) have either
a dominant within-subject variance or a dominant between-subject variance. In the remaining
50% voxels, both variance components have a significant impact. In conclusion, it cannot be
assumed that within-subject variance is negligible in comparison to between-subject variance.
4.2.2 Cross-subject comparison of within-subject variances
In this experiment, we tested whether within-subject variance could be assumed roughly constant
across subjects. As proposed by [27], we calculated an average within-subject variance across
voxels. This led to an index of within-subject variance per subject. Fig. 3 displays the within-
subject variance indexes in the control and patient groups.
In the control group, it is clear that one of the subjects presents an unexpected high variance
by comparison to the other controls. Retrospectively, we found out that this subject moved
substantially more than other controls and was identified as uncooperative by the MR physicist
during the acquisition. As expected from fig. 3, we found one outlier in the control group with
Rosner’s test.
The within-subject variance was significantly higher in the patient group than in the control
group (p < 0.05 with Kruskal-Wallis test). This might be explained by the fact that patients
tend to have more difficulties to lie still during the acquisition due to their pathological condition.
The index proposed by [27] is an average across voxels and therefore focused on global varia-
tions of the within-subject variance. However, strong variations, sometimes caused by artefacts,
that appear locally can also be a concern. As an example, fig. 4a displays the estimated within-
subject standard deviation for a control subject presenting locally atypical patterns. While the
high variance induced by the presence of large vessels is a pattern shared across subjects (as pre-
viously described in fig. 1, last panel), the high variance observed bilaterally in the frontal lobe is
specific of this control subject. We hypothesize that these strong variations are the consequence
of motion during the acquisition that was not correctly compensated during the pre-processing.
Even if this subject was not previously outlined as an outlier, these atypical patterns of variance
Inria
Importance of Heteroscedasticity in the Detection of Perfusion Abnormalities in ASL 17
Figure 4: a) Estimated within-subject standard deviation in a control subject presenting locally
atypical values. b) T1w map with false positive detections (in red) by leave-one-out cross-
validation (smoothing FWHM = 8 mm3) with the homoscedastic model (b) and the heterosce-
dastic model (c). No false positive detections are observed with the heteroscedastic model.
Table 1: Sensitivity and specificity in the control (first row) and patient (second and third
rows) groups with the homoscedastic and heteroscedastic models for different smoothing kernels
(FWHM = [0, 4, 6, 8, 10, 12] mm3), at p < 0.05 FDR corrected.
Homoscedastic model Heteroscedastic model
0 4 6 8 10 12 0 4 6 8 10 12
Specificity (controls) 1.00 0.99 0.99 0.99 0.99 0.99 1.00 1.00 1.00 1.00 1.00 1.00
Specificity (patients) 0.92 0.89 0.87 0.86 0.85 0.84 1.00 0.99 0.99 0.99 0.99 0.98
Sensitivity (hyper) 0.49 0.59 0.63 0.66 0.67 0.67 0.51 0.59 0.61 0.58 0.57 0.55
might have a detrimental impact on the analysis if not properly taken into account.
In conclusion, variations across subjects of the within-subject variance appear to be important
in ASL. This might be a consequence of the low SNR of this technique, since small artefacts in
the original control and labeled scans can lead to substantial variations in the perfusion-weighted
map after subtraction. In the next sections we investigate whether modeling heteroscedasticity
can improve the detections of perfusion abnormalities.
4.3 Comparison of homoscedastic and heteroscedastic models
In this subsection, the homoscedastic and heteroscedastic models are compared in term of sen-
sitivity and specificity to detect patient-specific perfusion abnormalities with ASL (as described
in 2.1.3).
4.3.1 Fixed threshold
Quantitative analysis Table 1 presents the sensitivity to detect hyper-perfusions and the
specificity both in the patient group and by leave-one-out cross-validation in the control group
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Figure 5: Detections of perfusion abnormalities with the homoscedastic and heteroscedastic
models in a patient suffering from a high grade glioma. a) T1w-Gd map, the tumor site is
pointed by a black arrow. b) Patient ASL CBF estimate βˆn . c) Within-subject standard devi-
ation of ASL CBF σˆ2n . d) T1w-Gd map with ground truth overlaid. T1w-Gd map with hypo-
(blue color-map) and hyper-perfusions (hot color-map) overlaid for the homoscedastic (e) and
heteroscedastic (f) models. Modeling heterogeneous variances (heteroscedastic model) reduces
the false positive detections while preserving the true detections. Axial slices are displayed in
neurological convention.
with the homoscedastic and heteroscedastic models for different smoothing kernels (FWHM = [0,
4, 6, 8, 10, 12] mm3), at p < 0.05 FDR corrected.
Overall, the heteroscedastic model leads to a decrease in false positive rate. This is par-
ticularly noticeable in the patient group where the specificity is improved for each smoothing
studied. As expected, in the control group, this effect is also observed but to a lesser extent. This
is probably due to the fact that the hypothesis of homoscedasticity is better suited for the control
subjects. The increase in false positive rate, with the homoscedastic model, is accompanied by
a relative increase in sensitivity, which does not seem significant given the specificity loss.
Qualitative analysis At the individual level, as illustrated in fig. 4, local atypical patterns
of variance can further lead to a substantial increase in false positives with the homoscedastic
model. The unexpected high standard deviation in the frontal lobe for the control subject pre-
sented in fig. 4 leads to false positive hyper-perfusions with the homoscedastic model whereas the
heteroscedastic model does not get any false positive (smoothing FWHM = 8 mm3). Fig. 5 fur-
ther illustrates the benefits of the heteroscedastic model compared to the homoscedastic model in
a patient subject. The motion artefacts and hyper-signals induced by arteries indeed correspond
to regions of high within-subject standard deviation. Modeling heterogeneous variances reduces
the artefactual detections in these regions while preserving the quality of the true detections.
To investigate whether, at a same specificity rate, the sensitivity differs between the two
approaches, we employed a ROC analysis as described in the next section.
4.3.2 ROC analysis
Quantitative comparison Fig. 6 presents the ROC curves in the patient group for the homo-
scedastic and heteroscedastic models. The average over the studied smoothing kernels is plotted
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Figure 6: ROC curves for perfusion abnormality detections with the homoscedastic and hetero-
scedastic models. The average ROC curves across the studied smoothings are plotted in plain
line. Dotted lines are plotted one standard deviation away from the average.
Table 2: Area under the ROC curve for false positive rates ranging between 0% and 10% with the
homoscedastic and heteroscedastic models. The heteroscedastic model outperforms the homo-
scedastic model.
Homoscedastic model Heteroscedastic model
0 4 6 8 10 12 0 4 6 8 10 12
Area under the ROC curve 0.46 0.49 0.49 0.49 0.48 0.48 0.63 0.70 0.72 0.72 0.69 0.65
along with the spread provided by the standard deviation over the 6 measurements. The ROC
curve of the heteroscedastic model is substantially closer to the ideal classifier than the homo-
scedastic curve.
Table 2 presents the area under the ROC curves for false positives rates ranging from 0 to
10%, for the homoscedastic and heteroscedastic models with different smoothing kernels. The
heteroscedastic model outperforms the homoscedastic model with an increased area under the
curve. The best values are 0.72 and 0.49 with the heteroscedastic and homoscedastic model
respectively. For both approaches, a maximum area under the curve is reached for a smoothing
kernel of 8 mm3.
Qualitative comparison In order to illustrate the advantage of the heteroscedastic over the
homoscedastic model, we chose 3 representative subjects and compared the methods at fixed
false positive rate and true positive rate. To this aim, we selected the uncorrected p-values that
would lead to a pre-specified false positive rate (respectively true positive rate) from the ROC
analysis. We worked with data smoothed with a Gaussian kernel of 8 mm3 that led to the best
area under the curve with both models. It is worth noting that in the previous section the
sensitivity and specificity were estimated at the group level and that the 3 subjects presented
in this part were chosen so that they would best illustrate the group findings. Fig. 7 presents
the detections obtained with both methods on the 3 selected patients. The first subject, which
presents a small hyper-perfusion, is studied at a true positive rate of 50%. In the two remaining
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patients, the methods are compared at a false positive rate of 0.1%.
Patient 15 suffers from a gliosarcoma in the left hemisphere close to the parahippocampal
region. The lesion displays a small hyper-perfusion in its dorsal part, small hypo-perfusions
are seen in the surrounding edema. At a false positive rate of 50%, the homoscedastic model
displays a larger number of false positives than the heteroscedastic model. Patient 16 was
diagnosed with a high grade tumor in the left temporal lobe. The lesion is characterized by
a large hyper-perfusion and a surrounding hypo-perfusion. With a false positive rate of 0.1%,
the hyper-perfusion is correctly located with both methods. The extent of the hyper-perfusion
is however better covered by the heteroscedastic model. Patient 6 suffers from a meningioma
partly hyperperfused. Similarly to patient 16, at a false positive rate of 0.1%, both methods
detect the hyper-perfusion but the heteroscedastic model is clearly more sensitive.
These 3 cases illustrate the loss of sensitivity of the homoscedastic model by comparison to
the heteroscedastic model at the same specificity level.
5 Discussion and conclusion
We have compared two approaches to quantitatively outline patient-specific pathological patterns
of abnormal perfusion in ASL data based on the massively univariate GLM: the homoscedastic
and heteroscedastic models.
We demonstrated that the assumptions underlying the homoscedastic model are not verified
in ASL studies. More precisely, the within-subject variance cannot be considered as negligible
by comparison to between-subject variance, nor constant across subjects. In fMRI data, small
deviations from homoscedasticity have shown to not overly alter the results in one-sample mixed-
effects GLM analysis [27]. Here, we showed that modeling heterogeneous within-subject variances
is essential in order to reach a satisfactory level of specificity in a mixed-effect two-sample t-test
comparing a patient to a group of controls in ASL. These results are in line with a recent study
by [11] where heteroscedastic mixed-effects GLM were shown to provide more accurate results
in fMRI.
In the context of this paper, we defined a single parameter in the subject-level design matrix
and focused on perfusion-weighted images obtained after pair-wise subtraction of the control
and labeled scans. Other authors have suggested that taking the complete ASL time-course into
account (before subtraction) would lead to more efficient estimates of perfusion in fMRI [26].
Also, additional regressors can be introduced as nuisance covariates for denoising purposes in
the subject-level design matrix as suggested in [42]. Modifying the subject-level design matrix
would change the estimated subject parameters and their sampling variances. However, an
heteroscedastic model would still be appropriate in this setting so that the conclusions of this
paper remain valid even with a different subject-level model.
We demonstrated that within-subject variance captures important information regarding the
subject-specific spatial distribution of noise in ASL data. We also outlined that patient-specific
brain perfusion abnormalities can be correctly detected using ASL if the heterogeneous within-
subject variances are properly modeled. We therefore advise the use of heteroscedastic models
in ASL studies.
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